XML 24 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Debt
6 Months Ended
Jun. 30, 2021
Debt Disclosure [Abstract]  
Debt

7. DEBT

Debt consisted of the following (in millions): 

 

 

June 30,

 

 

December 31,

 

 

June 30,

 

 

 

2021

 

 

2020

 

 

2020

 

Revolving credit facility

 

$

94.8

 

 

$

89.8

 

 

$

122.4

 

Other obligations

 

 

4.5

 

 

 

4.3

 

 

 

4.9

 

Total debt

 

 

99.3

 

 

 

94.1

 

 

 

127.3

 

Less current maturities of long-term debt

 

 

1.8

 

 

 

1.7

 

 

 

1.7

 

Long-term debt, less current maturities

 

$

97.5

 

 

$

92.4

 

 

$

125.6

 

 

 

Credit Facility — The Company has a $250.0 million asset-based senior secured revolving credit facility (the “credit facility”).  Borrowing availability under the credit facility is based on eligible accounts receivable, inventory and real estate. The real estate component of the borrowing base amortizes monthly over 12.5 years on a straight-line basis.  Borrowings under the credit facility are collateralized by substantially all of the Company’s assets, and the Company is subject to certain operating limitations applicable to a loan of this type, which, among other things, place limitations on indebtedness, liens, investments, mergers and acquisitions, dispositions of assets, cash dividends and transactions with affiliates.  The entire unpaid balance under the credit facility is due and payable on July 14, 2022. The Company is in discussions with prospective lenders to refinance its credit facility and expects to execute a new credit facility with the lenders during the third quarter of 2021. The Company believes that it is probable the new credit facility will be executed within this timeframe, and although unexpected events and conditions could influence the timing and completion of the new facility, the Company does not believe that is likely.  

At June 30, 2021, the Company had revolving credit borrowings of $94.8 million outstanding at a weighted average interest rate of 1.41% per annum, letters of credit outstanding totaling $3.2 million, primarily used as collateral for health and workers’ compensation insurance, and $97.8 million of excess committed borrowing availability.  The Company pays an unused commitment fee of 0.25% per annum. In addition, the Company had $0.9 million of other obligations maturing in 2023 at a borrowing rate of 6.11%. The Company also had $3.6 million of financing lease obligations at June 30, 2021.  See Note 4 – “Leases” for more information.  

The sole financial covenant in the credit facility is the minimum fixed charge coverage ratio (“FCCR”) of 1.00:1.00, which must be tested by the Company if the excess committed borrowing availability falls below an amount in the range of $17.5 million to $31.3 million, depending on the borrowing base. In the first six months of 2021, the Company was not required to test the minimum FCCR as excess borrowing availability was greater than the minimum threshold. If the Company’s availability would have fallen below that threshold, the Company would have met the minimum FCCR. The FCCR must also be tested on a pro forma basis prior to consummation of certain significant business transactions outside the ordinary course of business, as defined in the agreement. 

While the Company believes its cash on hand, borrowing capacity available under the existing credit facility and the anticipated new credit facility and cash flows from operations for the next twelve months will be sufficient to service its liquidity needs, it cannot predict whether future developments associated with the COVID-19 pandemic will materially adversely affect its liquidity position. See Note 13, “Impact of and Company Response to the COVID-19 Pandemic” for additional disclosure regarding the potential impact the current pandemic may have on the Company’s future liquidity and financial position.